Company: IMRX
Filing Date: 2025-09-25
Form Type: 8-K
Source: 0001104659-25-093436
Chunk: 4

Company: Immuneering Corp
Filing Date: 2025-09-25
Form: 8-K
Item: Item 9.01
Chunk 4
---
Item 9.01. Financial Statements and Exhibits.

(d) Exhibits

  Exhibit      Description                                                                                                                                         
      No.                                                                                                                                                          
      1.1      Underwriting Agreement, dated as of September 24, 2025, by and between Immuneering Corporation and Leerink Partners LLC and Oppenheimer & Co. Inc.  
 ───────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
      5.1      Opinion of Latham & Watkins LLP.                                                                                                                    
     23.1      Consent of Latham & Watkins LLP (included in Exhibit 5.1).                                                                                          
      104      Cover Page Interactive Data File (embedded within the inline XBRL document).                                                                        

SIGNATURES